HomeMETX • CNSX
add
ME Therapeutics Holdings Inc
Previous close
$2.50
Year range
$2.00 - $10.40
Market cap
73.97M CAD
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Simply Wall Street
20 minutes ago
AST SpaceMobile FCC Greenlight Puts Valuation And Execution In Focus
6.98%
Financials
Income Statement
Revenue
Net income
| (CAD) | Feb 2026info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 331.36K | 61.79% |
Net income | -289.22K | -44.63% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -288.88K | -45.53% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Feb 2026info | Y/Y change |
|---|---|---|
Cash and short-term investments | 856.67K | -57.14% |
Total assets | 1.20M | -48.66% |
Total liabilities | 158.07K | 8.80% |
Total equity | 1.04M | — |
Shares outstanding | 30.05M | — |
Price to book | 83.33 | — |
Return on assets | -60.14% | — |
Return on capital | -66.91% | — |
Cash Flow
Net change in cash
| (CAD) | Feb 2026info | Y/Y change |
|---|---|---|
Net income | -289.22K | -44.63% |
Cash from operations | -342.90K | -65.44% |
Cash from investing | -29.58K | 80.80% |
Cash from financing | -16.70K | -101.62% |
Net change in cash | -389.18K | -157.88% |
Free cash flow | -293.22K | 0.77% |
About
Founded
2014
Headquarters
Website
